Guías para tratamiento médico

2. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

3. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

4. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

5. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

6. Formación del
Lito
Inflamación
Grado de
Taponamiento
Duración de la
obstrucción
Taponamiento
del cuello o el
conducto cístico.
Patofisiología
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

7. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

8. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

9. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

10. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

11. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

12. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

13. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

14. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

15. USG: 50-88% S y 80-88 E.
a. Engrosamiento de la pared vesicular > 5
mm
b. Fluido pericolecistico.
c. Signo de Murphy USG
D. Cálculos
E. Gas vesicular.
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

16. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

17. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

18. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

19. Lawrence M. Knab et al..
Cholecystitis

20. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

21. Colecistitis enfisematosa
1. Engrosamiento irregular de la pared vesicular.
2. Imagen sugestiva de ruptura de la pared
3. Eco producido por el gas
.
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

22. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

23. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

24. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

25. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

26. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

27. Tomado de: Bile Duct Strictures. R Brugge et
al
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

28. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

29. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

30. Triada de Charcot: Baja S (26,4%), alta
E (95,9). 26-72% de todos los
pacientes.
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

31. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

32. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

33. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

34. 6. Disfunción Hematológica.
7.Trastorno de la conciencia.
8. Indice Kirby < 300
9. Oliguria, Creatinina > 2 mg/dl
10. PT/INR > 1,5
11. Conteo plaquetario: < 100
000.
12. hipotensión refractaria a
medicamentos.
TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

35. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

36. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

37. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

38. Grado I (Colecistitis o Colangitis): Cefotaxim + Metronidazol.
1 día de AB post Colecistectomía
Perforación, enfisematosa, 2-7 días post colecistectomía. (Colecistitis).
Colangitis: 4-7 días, bacteremia Gram + 2 semanas.
Grado II (Colecistitis o Colangitis): Cefepime, ceftazidima + metronizaol o Piperacilina tazobactan.
4-7 días, bacteremia Gram + 2 semanas.
Grado III (Colecistitis o Colangitis): Cefepime, ceftazidima + metronizaol, Piperacilna/tazobactan.
4-7 días, bacteremia Gram + 2 semanas. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

39. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

40. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

41. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

42. TG13: UpdatedTokyo Guide lines for acute cholangitis and
acute cholecystitis.
J Hepatobiliary Pancreat

44. Gracias